Business
Redwood Scientific Enters into Agreement with Jeeva Clinical Trials to Launch Clinical Effectiveness Study of its TBX-Free Oral Strips for Smoking and E-cigarette Cessation
Redwood Scientific Enters into Agreement with Jeeva Clinical Trials to Launch Clinical Effectiveness Study of its TBX-Free Oral Strips for Smoking and E-cigarette Cessation.
About this update from Redwood Scientific Technologies, Inc.
[{"type":"text","content":"\n\n\n\nRedwood Scientific Enters into Agreement with Jeeva Clinical Trials to Launch Clinical Effectiveness Study of its TBX-Free Oral Strips for Smoking and E-cigarette Cessation\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nRedwood Scientific Enters into Agreement with Jeeva Clinical Trials to Launch Clinical Effectiveness Study of its TBX-Free Oral Strips for Smoking and E-cigarette Cessation\nPR Newswire\nNEW YORK, Feb. 6, 2024\n\n\n\nCompany Has Engaged George Mason University to Conduct Efficacy Study on its New Product\nNEW YORK, Feb. 6, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI), (\"Redwood\" or \"the Company\"), a pioneering pharmaceutical company headquartered in New York, announced today that it has entered into an agreement with Jeeva Clinical Trials to launch a clinical effectiveness study of its TBX-Free oral strips products for smoking and e-cigarette cessation. The company has engaged top U.S. institution, George Mason University, to conduct the efficacy study on this new product.\n\n \n \n \n \n \n \n\n \n\"At Redwood Scientific Technologies, we are committed to developing safe and effective products to help the millions of adults and youths reclaim their lives from the clutches of nicotine addiction and collaborating with this prestigious group will help make this happen,\" said Jason Cardiff, Redwood's CEO. \"Recognizing the crisis at hand, especially with the youth, and the alarming levels of nicotine in vape devices, our goal is to bring this product to market promptly and into the hands of those in need.\"\nNicotine – found in cigarettes, vapes and e-cigarettes - is highly addictive, acting as both a stimulant and a sedative, and has severe adverse effects on every bodily system. It has been reported that 8 million adults in the U.S. regularly use e-cigarettes, with 28.3 million adults who regularly use traditional cigarettes. Of this number of users, 2.5 million middle and high school students use e-cigarettes, with 16.5 percent of high school students report current use of tobacc...